1 New Drug For IDH1 Mutation/Relapsed/Refractory Acute Myeloid Leukaemia With Good Complete Remission Rates And Manageable Toxicity Oct 27, 2024
Read More Apparatus Another Cancer-Independent Targeted Drug Approved! Up To 84% Efficacy! Apr 08, 2025
Read More Medical Cutting-Edge Targeted Drug For Cholangiocarcinoma Significantly Extends Patients' Lives! Apr 06, 2025
Read More Disease What Is The Difference Between Laryngeal Cancer And Pharyngitis? What Is The Way To Confirm The Diagnosis Of Laryngeal Cancer? Apr 15, 2025
